netFormulary Harrogate & Rural District Formulary NHS
Harrogate & District NHS Foundation Trust
Harrogate & Rural District Clinical Commissioning Group
 
 
 Search
 Formulary Chapter 11: Eye - Full Chapter
11.08.01  Expand sub section  Tear deficiency, ocular lubricants, and astringents
 note 

Guidelines for the Management of Dry Eyes in Primary & Secondary Care

Hypromellose
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice
Green
Eye drops 0.3% 
Carmellose Sodium 0.5% (Evolve)
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice
Green

First line if preservative-free option required

 
Carbomer 980 0.2% (Clinitas)
View adult BNF View SPC online View childrens BNF  Track Changes
Second Choice
Green

If thicker viscousity required

 
   
Carmellose 1%  (Celluvisc)
View adult BNF View SPC online View childrens BNF  Track Changes
Second Choice
Green

If thicker viscosity required (preservative-free)

 
   
Liquid Paraffin (Xailin Night or VitA Pos)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Eye ointment

 
   
Hyaluronic acid cross-linked (long-acting) (VisuXL)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber

For patients with compliance problems as BD dosing

 
   
Sodium hyaluronate 0.2% (Evolve HA )
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
 
   
Acetylcysteine 5% with Hypromellose 0.35% (Ilube)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
 
   
Ciclosporin 1mg/mL Eye Drops (Ikervis)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber

Approved in line with NICE TA369

 
Link  NICE TA369: Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears
   
 ....
 Non Formulary Items
Acetylcysteine

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Hydroxyethylcellulose  (Minims Artificial Tears)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Hydroxypropyl Guar  (Systane®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Hypromellose 0.3% with Dextran 70 0.1%  (Tears naturale)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Paraffin Yellow Soft  (Simple Eye Ointment)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Polyvinyl Alchohol  (SnoTears)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary
Green

Eye drops 1.4%

 
Polyvinyl Alcohol  (Liquifilm Tears)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary
Green

Single dose eye drops 1.4%

 
Providone  (Oculotect)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sodium Chloride  (Balanced Salt Solution)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sodium Hyaluronate  (Hylo-Forte®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sodium Hyaluronate  (Hylo-Tear®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sodium hyaluronate 0.1% and carmellose sodium 0.5%  (Optive Fusion)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary
Green
Eye drops - 10ml bottle
 
Zinc Sulphate

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Amber

Medicines which are suitable to be prescribed in primary care only after specialist recommendation. Ongoing prescribing by primary care includes titration of dose and assessment of efficacy. There is no need for ongoing monitoring other than for general adverse effects as listed in the BNF & SPC.  

Amber Shared Care

Medicines which are suitable to be prescribed in primary care only after specialist recommendation only under a shared care protocol once the patient has been stabilised. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must be approved by the Harrogate & Rurual District Area Prescribing Committee (HaRD APC).   

Black

Medicines which the Harrogate & Rural District Area Prescribing Committee (HaRD APC) has reviewed and does not recommend for use at present based on a review of clinical and/or cost effectiveness data.   

Green

Medicines suitable for routine use and can be prescribed within primary care within their licensed indication in accordance with nationally recognised formularies e.g. BNF, BNF for Children, Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.  

Grey

Medicines which the Harrogate & Rural District Area Prescribing Committee (HaRD APC) have not yet reviewed.   

Red

Medicines for hospital use only. The responsibility for initiation and monitoring treatment should rest with an appropriate hospital clinician. The drug should be supplied by the hospital for the duration of the treatment course. Primary care prescriber initiation or continuation of treatemnt is not recommended.  

netFormulary